1. Anti-Gal and Anti-Neu5Gc Responses in Nonimmunosuppressed Patients After Treatment With Rabbit Antithymocyte Polyclonal IgGs. Issue 10 (October 2017) Authors: Salama, Apolline; Evanno, Gwénaëlle; Lim, Noha; Rousse, Juliette; Le Berre, Ludmilla; Nicot, Arnaud; Bach, Jean-Marie; Brouard, Sophie; Harris, Kristina M.; Ehlers, Mario R.; Gitelman, Stephen E.; Soulillou, Jean-Paul Journal: Transplantation Issue: Volume 101:Issue 10(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Changes in T‐cell subsets identify responders to FcR‐nonbinding anti‐CD3 mAb (teplizumab) in patients with type 1 diabetes. Issue 1 (14th December 2015) Authors: Tooley, James E.; Vudattu, Nalini; Choi, Jinmyung; Cotsapas, Chris; Devine, Lesley; Raddassi, Khadir; Ehlers, Mario R.; McNamara, James G.; Harris, Kristina M.; Kanaparthi, Sai; Phippard, Deborah; Herold, Kevan C. Journal: European journal of immunology Issue: Volume 46:Issue 1(2016) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Strategies for clinical trials in type 1 diabetes. (July 2016) Authors: Ehlers, Mario R. Journal: Journal of autoimmunity Issue: Volume 71(2016) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗